Cefditoren

Cefditoren
Clinical data
Trade names Spectracef
AHFS/Drugs.com Monograph
MedlinePlus a605003
ATC code J01DD16 (WHO)
Identifiers
CAS Number 104145-95-1 N
PubChem (CID) 9870843
DrugBank DB01066 YesY
ChemSpider 8046534 YesY
UNII 81QS09V3YW YesY
KEGG D07639 N
ChEBI CHEBI:59343 YesY
ChEMBL CHEMBL610374 N
ECHA InfoCard 100.214.754
Chemical and physical data
Formula C19H18N6O5S3
Molar mass 506.58 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Vansen Pharma Inc.

Cefditoren is also marketed under the name Meiact by Meiji Seika Pharma Co., Ltd.[1]

Spectrum of bacterial susceptibility

Cefditoren has a broad spectrum of activity and has been used to treat bacterial infections of the skin and respiratory tract, including bronchitis, pneumonia, and tonsillitis. The following represents MIC susceptibility data for a few medically significant microorganisms.

Cefditoren is a broad-spectrum antibiotic against Gram-negative and Gram-positive bacteria, but does not have antibacterial activity against Pseudomonas aeruginosa.[3]

Clinical use

Main article: Cephalosporin

Indications

Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis, pharyngitis, and tonsillitis.

Formulations

Cefditoren is available as 200- and 400-mg tablets. It can be formulated as the prodrug cefditoren pivoxil.

Chemical structure of cefditoren pivoxil

References

This article is issued from Wikipedia - version of the 10/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.